Form 4 for PASG Passage BIO, Inc.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-10 · accession 0001415889-24-003640 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-10 | PASG | Borthwick Kathleen | SVP, INTERIM CFO | M - OptEx | — | +4,000 | 29.9K | +15% | — |
| D | 2024-02-13 | 2024-02-13 | PASG | Borthwick Kathleen | SVP, INTERIM CFO | S - Sale+OE | $0.97 | -1,470 | 28.5K | -5% | -$1,426 |
| D | 2024-02-13 | 2024-02-10 | PASG | Borthwick Kathleen | SVP, INTERIM CFO | M - OptEx | $0.00 | -4,000 | 8,000 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-10 | M | A | 4,000 | — | 29,936 | D | — | — | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-02-13 | S | D | 1,470 | $0.97 | 28,466 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-02-10 | M | D | 4,000 | $0.00 | 8,000 | D | — · — to — | 4,000 Common Stock | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F3) 1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. |